New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Smoking linked to melanoma-associated death in early-stage melanoma

Smoking linked to melanoma-associated death in early-stage melanoma

by Elana GotkineFor patients with clinical stage I and II melanoma, smoking is associated with an increased risk for melanoma-associated death, according to a study published online Feb. 6 inJAM
Oncology March 05,2024
Smoking linked to melanoma-associated death in early-stage melanoma

Smoking linked to melanoma-associated death in early-stage melanoma

by Elana GotkineFor patients with clinical stage I and II melanoma, smoking is associated with an increased risk for melanoma-associated death, according to a study published online Feb. 6 inJAM
Oncology March 05,2024
Research shows effectiveness of new technique to detect ovarian cancer marker peptides

Research shows effectiveness of new technique to detect ovarian cancer marker peptides

by Brian McNeill,Virginia Commonwealth UniversityVCU physics doctoral candidates Mohammed Almahyawi and Thomas W. Rockett demonstrate the setup of their nanopore research that could one day help
Oncology March 05,2024
Research shows effectiveness of new technique to detect ovarian cancer marker peptides

Research shows effectiveness of new technique to detect ovarian cancer marker peptides

by Brian McNeill,Virginia Commonwealth UniversityVCU physics doctoral candidates Mohammed Almahyawi and Thomas W. Rockett demonstrate the setup of their nanopore research that could one day help
Oncology March 05,2024
Cytometry chip supports new revolution in cancer care for a truly personalized treatment plan

Cytometry chip supports new revolution in cancer care for a truly personalized treatment plan

by IMECImec's cell sorter concept uses integrated star-shaped microheaters to push the target cells into a side channel. Credit: IMECImec teamed up with the KU Leuven laboratory of tumor immu
Oncology March 05,2024
Cytometry chip supports new revolution in cancer care for a truly personalized treatment plan

Cytometry chip supports new revolution in cancer care for a truly personalized treatment plan

by IMECImec's cell sorter concept uses integrated star-shaped microheaters to push the target cells into a side channel. Credit: IMECImec teamed up with the KU Leuven laboratory of tumor immu
Oncology March 05,2024
Simulation training reduces birth-related risks for pregnant women

Simulation training reduces birth-related risks for pregnant women

by Eindhoven University of TechnologyCredit: CC0 Public DomainTeam training in obstetrics teams in hospitals helps reduce harm to new-born babies in the event of acute complications during birth.
OB & GYN March 05,2024
Simulation training reduces birth-related risks for pregnant women

Simulation training reduces birth-related risks for pregnant women

by Eindhoven University of TechnologyCredit: CC0 Public DomainTeam training in obstetrics teams in hospitals helps reduce harm to new-born babies in the event of acute complications during birth.
OB & GYN March 05,2024
With vibrator used in cell phones, researchers develop 3D tumor spheroids to screen for anti-cancer drugs

With vibrator used in cell phones, researchers develop 3D tumor spheroids to screen for anti-cancer drugs

by Brigham and Women’s HospitalCredit:Device(2024). DOI: 10.1016/j.device.2024.100255Depending on their location, cancer cells within a three-dimensional (3D) tumor structure can have
Oncology March 05,2024
With vibrator used in cell phones, researchers develop 3D tumor spheroids to screen for anti-cancer drugs

With vibrator used in cell phones, researchers develop 3D tumor spheroids to screen for anti-cancer drugs

by Brigham and Women’s HospitalCredit:Device(2024). DOI: 10.1016/j.device.2024.100255Depending on their location, cancer cells within a three-dimensional (3D) tumor structure can have
Oncology March 05,2024
New approach combines oncolytic virotherapy and adoptive T cell therapy for cancer treatment

New approach combines oncolytic virotherapy and adoptive T cell therapy for cancer treatment

by Bob Yirka , Medical XpressScheme of genome editing of PDL1 by eOA effectively improved virotherapy and adoptive T-cell therapy. Credit:Nature Biotechnology(2024). DOI: 10.1038/s41587-02
Oncology March 05,2024
New approach combines oncolytic virotherapy and adoptive T cell therapy for cancer treatment

New approach combines oncolytic virotherapy and adoptive T cell therapy for cancer treatment

by Bob Yirka , Medical XpressScheme of genome editing of PDL1 by eOA effectively improved virotherapy and adoptive T-cell therapy. Credit:Nature Biotechnology(2024). DOI: 10.1038/s41587-02
Oncology March 05,2024
The HILPDA protein: A potential biomarker for new treatment options in aggressive kidney cancer

The HILPDA protein: A potential biomarker for new treatment options in aggressive kidney cancer

by Karolinska InstitutetCredit:Proceedings of the National Academy of Sciences(2024). DOI: 10.1073/pnas.2310479121Anew studyfrom Karolinska Institutet discovered that bloc
Oncology March 05,2024
The HILPDA protein: A potential biomarker for new treatment options in aggressive kidney cancer

The HILPDA protein: A potential biomarker for new treatment options in aggressive kidney cancer

by Karolinska InstitutetCredit:Proceedings of the National Academy of Sciences(2024). DOI: 10.1073/pnas.2310479121Anew studyfrom Karolinska Institutet discovered that bloc
Oncology March 05,2024
Researchers report on ctDNA-based detection of residual disease prognostic for resected CRC

Researchers report on ctDNA-based detection of residual disease prognostic for resected CRC

by Elana GotkineFor patients with radically resected, stage II to IV colorectal cancer (CRC), circulating tumor (ct)DNA-based detection of molecular residual disease (MRD) in response to adjuvant chem
Oncology March 05,2024
Researchers report on ctDNA-based detection of residual disease prognostic for resected CRC

Researchers report on ctDNA-based detection of residual disease prognostic for resected CRC

by Elana GotkineFor patients with radically resected, stage II to IV colorectal cancer (CRC), circulating tumor (ct)DNA-based detection of molecular residual disease (MRD) in response to adjuvant chem
Oncology March 05,2024
Study suggests many perceive pregnancy as predetermined

Study suggests many perceive pregnancy as predetermined

by The City University of New YorkCredit: CC0 Public DomainIn the attempt to gauge need for contraception or reproductive health services, researchers and clinicians often query women about pregn
OB & GYN March 05,2024
Study suggests many perceive pregnancy as predetermined

Study suggests many perceive pregnancy as predetermined

by The City University of New YorkCredit: CC0 Public DomainIn the attempt to gauge need for contraception or reproductive health services, researchers and clinicians often query women about pregn
OB & GYN March 05,2024
Method that rapidly predicts breast cancer survival rates clinically validated

Method that rapidly predicts breast cancer survival rates clinically validated

by Ian Mundell,Imperial College LondonFlow diagram of the Digistain protocol. Credit:Breast Cancer Research and Treatment(2024). DOI: 10.1007/s10549-023-07229-yDigistain, a company w
Oncology March 05,2024
Method that rapidly predicts breast cancer survival rates clinically validated

Method that rapidly predicts breast cancer survival rates clinically validated

by Ian Mundell,Imperial College LondonFlow diagram of the Digistain protocol. Credit:Breast Cancer Research and Treatment(2024). DOI: 10.1007/s10549-023-07229-yDigistain, a company w
Oncology March 05,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com